Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
245 participants
OBSERVATIONAL
2009-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Previous studies from our lab have suggested that it is possible to compute the mechanical strength of bones with tumors using computed tomography (CT) scans, which are like three-dimensional X-ray pictures of the affected bones.
The next step in determining the usefulness of this type of strength analysis is to see if we can accurately predict who is at risk for bone fracture and which patients are at high risk of fractures.
This non-invasive analysis may help physicians determine the best treatment to reduce the risk of an impending bone fracture in the future.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
NCT02355340
Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging
NCT01374412
A Natural History Study of Bone and Mineral Disorders
NCT00024804
CT-Based Deep Learning for Differentiating Acute and Chronic Osteoporotic Vertebral Compression Fractures
NCT07306858
A Study on Vertebral Bone Strength by Micro-CT-Like Image
NCT04954417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The treating physician has ordered both an X-ray picture and a three-dimensional CT scan image of the involved bone plus the contralateral limb (lower limbs). He/she will be provided with a standard report from the radiologist describing the appearance of the bone tumor and the bone itself which the treating physician will use to determine the course of treatment he/she deems appropriate. We will perform a special analysis of the CT images that will allow us to estimate the strength of the bone with the tumor. Based on this engineering analysis of the strength of the bone, the treating physician may alter the prescribed treatment to decrease the risk that bone will fracture. If the patient does not have a fracture within the follow-up period (four months), he/she will undergo a second CT scan to determine the response of the tumor to treatment and changes in the strength of the bone. If the patient does have a fracture within the follow-up period, he/she will undergo a second CT scan to determine the integrity of the remaining bone to help your physician plan the next course of action. We will use the second CT scan to estimate how weak the bone was just prior to fracture. In either case, the patient's participation in this study will be concluded after the second CT scan.
Patient participation in the study will last four months. If the patient has a fracture before four months, his/her participation will end at that time.
The investigator and/or the treating physician may decide to take the patient off this study if
1. patient refuses or is unable to complete study procedures;
2. patient develops weakness or numbness in his/her limbs due to your disease;
3. patient's bone fractures due to significant trauma (e.g., traffic accident, fall from height);
4. a different bone fractures, limiting patient's ability to put pressure on the bone of interest; or
5. patient relocate.
The patient can end his/her participation at any time. The patient's decision to withdraw from the study will not affect in any way his/her medical care and/or benefits. If the patient decides to end his/her participation in the study, we encourage him/her to discuss the decision the treating physician.
STUDY LOCATION Privacy Patients will be approached by treating physicians at clinic and privately (in the examination room), where they can privately describe the study, answer any questions the patient might have and potentially enroll the patient in the study. Patient privacy and confidentiality will be strictly observed during all steps of recruitment, reporting of data and follow up conversations.
Physical Setting
All patient related activity will be conducted in the hospital as the patient undergoes treatment. CT data analysis will be performed at the Center for advanced Orthopaedic Studies at BIDMC.
DATA SECURITY All data will be kept behind BIDMC firewall at an access controlled computer designated for this study only. Additionally, the patient data will be anonymized and a number will be assigned to protect the patient identity, therefore those conducting analysis on the CT data will have no access to patient identifiable information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ara Nazarian
Assistant Professor of Orthopedic Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alvin and Lois Lapidus Cancer Center, Sinai Hospital of Baltimore, Inc
Baltimore, Maryland, United States
Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, Massachusetts, United States
Department of Orthopaedic Surgery, University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Department of Orthopedic Surgery, Upstate Medical University
Syracuse, New York, United States
Department of Orthopaedic Surgery, Rhode Island Hospital
Providence, Rhode Island, United States
Section of Orthopaedic Oncology, University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Edwards Comprehensive Cancer Center, Marshall University
Huntington, West Virginia, United States
Department of Orthopaedic Surgery, McGill University Health Centre
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Guide website to join this study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008P000285
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.